The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study

Botulinum Neurotoxin type-A (BoNT-A) is the treatment of choice for focal post-stroke spasticity (PSS). Due to its mechanism of action and the administration method, some authors raised concern about its possible systemic diffusion leading to contralateral muscle weakness and autonomic nervous syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Battaglia, Marco, Borg, Margherita Beatrice, Torgano, Lara, Loro, Alberto, Cosenza, Lucia, Bertoni, Michele, Picelli, Alessandro, Santamato, Andrea, Invernizzi, Marco, Uberti, Francesca, Molinari, Claudio, Carda, Stefano, Baricich, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414297/
https://www.ncbi.nlm.nih.gov/pubmed/36006227
http://dx.doi.org/10.3390/toxins14080564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414297/
https://www.ncbi.nlm.nih.gov/pubmed/36006227
http://dx.doi.org/10.3390/toxins14080564

Ejemplares similares